Completed Clinical Trials

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

By April 24, 2017 No Comments


Malignant Pleural Mesotheliomas

Estimated Enrollment: 50

Age Group: 39 Years to 84 Years   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Retrospective

Study ID Numbers: DR-81

Study First Received: October 28, 2015

Last Updated: May 29, 2016

Estimated Primary Completion Date: May 2016


Primary Outcome Measures:

to correlate the results of the vascularity marker of pleural mesothelioma CD74 of patients attended to Ain Shams University hospitals with the result response of treatment by chemotherapy ,overall survival and progreeion free survival|assessment of vascular enothelial growth factor (VEGF) in patient with malignant pleural mesothelioma who attended to Ain Shams University and made comparison with the result of CD 74

Sponsors and Collaborators:

Ain Shams University

Website Link:

Leave a Reply

Call Now